News & Events zu Haemonetics Corp (HAE)HAEHaemonetics Corp

Haemonetics Q1 Revenue $339.38M, Exceeds Expectations

Reports Q1 revenue $339.38M, consensus $327.89M. Chris Simon, Haemonetics' CEO, stated: "We had a strong start to fiscal 2027, gaining Plasma share, sustaining Blood Management Technologies momentum, and returning Interventional Technologies to growth. With our evolved portfolio, transformed operating model and disciplined execution, we are strengthening our competitive position and demonstrating the durable growth of our diversified businesses. We raised full-year guidance, and Haemonetics is well-positioned to deliver sustainable long term growth and shareholder value."

Raises FY27 Revenue Outlook to Increase 5%-8%

Raises FY27 revenue view to up 5%-8% from up 4%-7%.